DDR Gene Mutation
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of LP-184 in Patients With Advanced Solid Tumors (NCT05933265) | Lantern Pharma Inc. | 2023-06-09 |
| A Phase II Study of Nivolumab in Patients With Genetic Alterations in DNA Damage Repair and Response Who Progressed After Standard Treatment for Metastatic Solid Cancers (NCT04761744) | Korean Cancer Study Group | 2019-06-14 |
Track DDR Gene Mutation automatically
Every clearance here is in the API, with alerts when new ones post.